professional documents
home
Upload
docsters
Upload
Page 4 Expedite-Rx SPC Global Technologies, Ltd. Employer Health Options, Inc. January 22, 2004 Action Needed . This letter is not intended to identify all of the ways in which your activities violate U.S. law. It is your responsibility to ensure that you are in compliance with applicable legal requirements. Please notify this office in writing within fifteen (15) working days of your receipt ofthis letter of the specific steps you will take to assure that your operations are in full compliance with u.S. law. Please address your correspondence to Mr. Melvin Szymanski, Compliance Officer, at the U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Office of Compliance, HFD-310, 5600 Fishers Lane, Rockville, MD 20857. If you do not promptly correct your violations, FDA may take legal action without further notice. Possible actions include seizure and/or injunction. Further, federal agencies are advised ofthe issuance of all Warning Letters about drugs so that they may take this information into account when considering the award of contracts. Sincerely, David J. Horowitz, Esq. Director Office of Compliance Center for Drug Evaluation and Research Food and Drug Administration ~~
flag this doc
113
0
not rated
0
5/5/2008
English
Preview

FDA A fillable

GovernmentDocs 5/4/2008 | 403 | 4 | 0 | legal
Preview

Page Expedite Rx SPC Global Technologies Ltd Employer Warning Letters.

FDADocs 5/9/2008 | 37 | 0 | 0 | legal
Preview

FDA Information Page

FDADocs 5/9/2008 | 103 | 0 | 0 | legal
Preview

DOCUMENT INFORMATION PAGE This page is for FDA FDA Table of Contents

FDADocs 5/9/2008 | 71 | 1 | 0 | legal
Preview

FDA Regulatory Pathway Annual FDA and the Changing

GovernmentDocs 5/4/2008 | 166 | 2 | 0 | legal
Preview

Irradiation of Food An FDA Perspective Packaging

FDADocs 5/8/2008 | 119 | 1 | 0 | legal
Preview

Irradiation of Food An FDA Perspective

GovernmentDocs 5/4/2008 | 136 | 2 | 0 | legal
Preview

FDA Assistance to Industry

FDADocs 5/9/2008 | 139 | 1 | 0 | legal
Preview

FDA s Accomplishments in 2005

FDADocs 5/9/2008 | 92 | 0 | 0 | legal
Preview

FDA Receipt for Samples

FDADocs 5/9/2008 | 140 | 1 | 0 | legal
Preview

AFFIDAVIT IN TRANSIT FDA

FDADocs 5/9/2008 | 76 | 0 | 0 | legal
Preview

FDA Field Inspections

FDADocs 5/5/2008 | 112 | 0 | 0 | legal
Preview

FDA Organizational Chart

FDADocs 5/8/2008 | 313 | 3 | 0 | legal
Preview

FDA in the International Community

FDADocs 5/9/2008 | 111 | 0 | 0 | legal
Preview

NOTICE OF FDA ACTION

FDADocs 5/9/2008 | 133 | 0 | 0 | legal
Preview

Migranal Dihydroergotamine Mesylate Nasal Spray D H E Injection

GovernmentDocs 5/5/2008 | 208 | 0 | 0 | legal
Preview

Allegra fexofenadine HCl Tablets

GovernmentDocs 5/5/2008 | 184 | 0 | 0 | legal
Preview

Bexxar tositumomab and iodine I tositumomab

GovernmentDocs 5/5/2008 | 117 | 0 | 0 | legal
Preview

Paxil CR paroxetine HCl

GovernmentDocs 5/5/2008 | 346 | 0 | 0 | legal
Preview

Viramune nevirapine Tablets and Viramune nevirapine Oral Suspension

GovernmentDocs 5/5/2008 | 104 | 0 | 0 | legal
Preview

Viadur leuprolide acetate implant

GovernmentDocs 5/5/2008 | 104 | 0 | 0 | legal
Preview

Topamax topiramate Tablets and Topamax topiramate capsules Sprinkles

GovernmentDocs 5/5/2008 | 195 | 0 | 0 | legal
Preview

Duragesic fentanyl transdermal system 2004

GovernmentDocs 5/5/2008 | 137 | 0 | 0 | legal
Preview

Kaletra lopinavir ritonavir Capsules and Oral Suspension

GovernmentDocs 5/5/2008 | 64 | 0 | 0 | legal
 
review this doc